{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:49:46Z","timestamp":1791002986956,"version":"4.1.0"},"reference-count":116,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T00:00:00Z","timestamp":1559606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011110","name":"UCB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011110","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005366","name":"Universitetet i Oslo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["179573\/V40"],"award-info":[{"award-number":["179573\/V40"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","award":["2011050"],"award-info":[{"award-number":["2011050"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","award":["2015009"],"award-info":[{"award-number":["2015009"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010795","name":"Chugai Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.molmed.2019.05.009","type":"journal-article","created":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T08:18:30Z","timestamp":1563524310000},"page":"836-852","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Therapeutic and Diagnostic Implications of T Cell Scarring in Celiac Disease and Beyond"],"prefix":"10.1016","volume":"25","author":[{"given":"Asbj\u00f8rn","family":"Christophersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise F.","family":"Risnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiva","family":"Dahal-Koirala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludvig M.","family":"Sollid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2019.05.009_bb0005","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nrg3502","article-title":"Genetic insights into common pathways and complex relationships among immune-mediated diseases","volume":"14","author":"Parkes","year":"2013","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.molmed.2019.05.009_bb0010","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nri885","article-title":"Coeliac disease: dissecting a complex inflammatory disorder","volume":"2","author":"Sollid","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molmed.2019.05.009_bb0015","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/gut.50.5.624","article-title":"The first large population based twin study of coeliac disease","volume":"50","author":"Greco","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.molmed.2019.05.009_bb0020","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/01.mpg.0000189337.08139.83","article-title":"Serologic and genetic markers of celiac disease: a sequential study in the screening of first degree relatives","volume":"42","author":"Bonamico","year":"2006","journal-title":"J.\u00a0Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.molmed.2019.05.009_bb0025","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nm0797-797","article-title":"Identification of tissue transglutaminase as the autoantigen of celiac disease","volume":"3","author":"Dieterich","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2019.05.009_bb0030","doi-asserted-by":"crossref","DOI":"10.1177\/2050640619844125","article-title":"European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders","author":"Al-Toma","year":"2019","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.molmed.2019.05.009_bb0035","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S1542-3565(05)00532-X","article-title":"Celiac disease genetics: current concepts and practical applications","volume":"3","author":"Sollid","year":"2005","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.molmed.2019.05.009_bb0040","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.4049\/jimmunol.1501152","article-title":"Healthy HLA-DQ2.5+ subjects lack regulatory and memory T\u00a0cells specific for immunodominant gluten epitopes of celiac disease","volume":"196","author":"Christophersen","year":"2016","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.molmed.2019.05.009_bb0045","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/nri3407","article-title":"Triggers and drivers of autoimmunity: lessons from coeliac disease","volume":"13","author":"Sollid","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molmed.2019.05.009_bb0050","first-page":"1","article-title":"Antigen-based immunotherapy for autoimmune disease: current status","volume":"4","author":"Hirsch","year":"2015","journal-title":"Immunotargets Ther."},{"key":"10.1016\/j.molmed.2019.05.009_bb0055","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.addr.2015.10.020","article-title":"Combining antigen and immunomodulators: Emerging trends in antigen-specific immunotherapy for autoimmunity","volume":"98","author":"Northrup","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.molmed.2019.05.009_bb0060","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1084\/jem.20082118","article-title":"Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10-secreting Th1 cells","volume":"206","author":"Gabrysova","year":"2009","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.molmed.2019.05.009_bb0065","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.4049\/jimmunol.177.6.4178","article-title":"Gliadin-specific type 1 regulatory T\u00a0cells from the intestinal mucosa of treated celiac patients inhibit pathogenic T\u00a0cells","volume":"177","author":"Gianfrani","year":"2006","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.molmed.2019.05.009_bb0070","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1053\/j.gastro.2011.04.048","article-title":"Tolerance to ingested deamidated gliadin in mice is maintained by splenic, type 1 regulatory T\u00a0cells","volume":"141","author":"du Pre","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.molmed.2019.05.009_bb0075","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00251-012-0599-z","article-title":"Nomenclature and listing of celiac disease relevant gluten T-cell epitopes restricted by HLA-DQ molecules","volume":"64","author":"Sollid","year":"2012","journal-title":"Immunogenetics"},{"key":"10.1016\/j.molmed.2019.05.009_bb0080","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S2468-1253(17)30110-3","article-title":"Epitope-specific immunotherapy targeting CD4-positive T\u00a0cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies","volume":"2","author":"Goel","year":"2017","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.molmed.2019.05.009_bb0085","doi-asserted-by":"crossref","first-page":"e955","DOI":"10.1212\/WNL.0000000000005118","article-title":"Effects of ATX-MS-1467 immunotherapy over 16\u00a0weeks in relapsing multiple sclerosis","volume":"90","author":"Chataway","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.molmed.2019.05.009_bb0090","doi-asserted-by":"crossref","first-page":"11109","DOI":"10.1021\/acs.chemrev.5b00109","article-title":"Synthetic Nanoparticles for Vaccines and Immunotherapy","volume":"115","author":"Irvine","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.molmed.2019.05.009_bb0095","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.immuni.2016.04.020","article-title":"CD28 Costimulation: From Mechanism to Therapy","volume":"44","author":"Esensten","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2019.05.009_bb0100","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/nature16962","article-title":"Expanding antigen-specific regulatory networks to treat autoimmunity","volume":"530","author":"Clemente-Casares","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2019.05.009_bb0105","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.immuni.2010.03.015","article-title":"Reversal of autoimmunity by boosting memory-like autoregulatory T\u00a0cells","volume":"32","author":"Tsai","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2019.05.009_bb0110","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.3389\/fimmu.2017.01961","article-title":"Lactococcus lactis As a Versatile Vehicle for Tolerogenic Immunotherapy","volume":"8","author":"Cook","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molmed.2019.05.009_bb0115","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.4049\/jimmunol.0802891","article-title":"Induction of antigen-specific tolerance by oral administration of Lactococcus lactis delivered immunodominant DQ8-restricted gliadin peptide in sensitized nonobese diabetic Abo Dq8 transgenic mice","volume":"183","author":"Huibregtse","year":"2009","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.molmed.2019.05.009_bb0120","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3389\/fimmu.2018.00230","article-title":"Nanoparticles for the Induction of Antigen-Specific Immunological Tolerance","volume":"9","author":"Kishimoto","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molmed.2019.05.009_bb0125","article-title":"Overcoming challenges in treating autoimmuntity: Development of tolerogenic immune-modifying nanoparticles","author":"Pearson","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.molmed.2019.05.009_bb0130","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1073\/pnas.1701746114","article-title":"Engineered erythrocytes covalently linked to antigenic peptides can protect against autoimmune disease","volume":"114","author":"Pishesha","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2019.05.009_bb0135","doi-asserted-by":"crossref","DOI":"10.1038\/srep15907","article-title":"Memory of tolerance and induction of regulatory T\u00a0cells by erythrocyte-targeted antigens","volume":"5","author":"Grimm","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molmed.2019.05.009_bb0140","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/imr.12535","article-title":"Restimulation-induced cell death: new medical and research perspectives","volume":"277","author":"Zheng","year":"2017","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.molmed.2019.05.009_bb0145","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s41591-019-0403-9","article-title":"Distinct phenotype of CD4(+) T\u00a0cells driving celiac disease identified in multiple autoimmune conditions","volume":"25","author":"Christophersen","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2019.05.009_bb0150","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1146\/annurev-immunol-042617-053019","article-title":"Unraveling the Complex Interplay Between T Cell Metabolism and Function","volume":"36","author":"Geltink","year":"2018","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.molmed.2019.05.009_bb0155","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aao5563","article-title":"Teriflunomide treatment for multiple sclerosis modulates T\u00a0cell mitochondrial respiration with affinity-dependent effects","volume":"11","author":"Klotz","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.molmed.2019.05.009_bb0160","doi-asserted-by":"crossref","first-page":"110","DOI":"10.4049\/jimmunol.1701133","article-title":"STAT5B: A Differential Regulator of the Life and Death of CD4(+) Effector Memory T Cells","volume":"200","author":"Majri","year":"2018","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.molmed.2019.05.009_bb0165","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/jlcr.3622","article-title":"Aligning physics and physiology: Engineering antibodies for radionuclide delivery","volume":"61","author":"Tsai","year":"2018","journal-title":"J.\u00a0Labelled Comp. Radiopharm."},{"key":"10.1016\/j.molmed.2019.05.009_bb0170","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1146\/annurev-med-061516-121357","article-title":"Antibody-Drug Conjugates for Cancer Treatment","volume":"69","author":"Lambert","year":"2018","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.molmed.2019.05.009_bb0175","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.immuni.2016.04.017","article-title":"Co-stimulatory and Co-inhibitory Pathways in Autoimmunity","volume":"44","author":"Zhang","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2019.05.009_bb0180","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.3389\/fimmu.2018.02306","article-title":"Immune Checkpoints as Therapeutic Targets in Autoimmunity","volume":"9","author":"Paluch","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molmed.2019.05.009_bb0185","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature20810","article-title":"Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis","volume":"542","author":"Rao","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2019.05.009_bb0190","article-title":"Immune checkpoint inhibitor PD-1 pathway is down-regulated in synovium at various stages of rheumatoid arthritis disease progression","volume":"13","author":"Guo","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.molmed.2019.05.009_bb0195","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s40265-017-0775-4","article-title":"Abatacept: A Review in Rheumatoid Arthritis","volume":"77","author":"Blair","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.molmed.2019.05.009_bb0200","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0140-6736(11)60886-6","article-title":"Co-stimulation modulation\u00a0with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial","volume":"378","author":"Orban","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.molmed.2019.05.009_bb0205","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/annrheumdis-2014-206106","article-title":"Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of\u00a024\u00a0months, with a 12-month, double-blind\u00a0treatment period","volume":"74","author":"Emery","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.molmed.2019.05.009_bb0210","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s40259-018-0303-4","article-title":"Small-Molecule Immune Checkpoint Inhibitors Targeting PD-1\/PD-L1 and Other Emerging Checkpoint Pathways","volume":"32","author":"Sasikumar","year":"2018","journal-title":"BioDrugs"},{"key":"10.1016\/j.molmed.2019.05.009_bb0215","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3389\/fimmu.2014.00472","article-title":"A Short History of the B-Cell-Associated Surface Molecule CD40","volume":"5","author":"Clark","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molmed.2019.05.009_bb0220","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1136\/annrheumdis-2017-211388","article-title":"Repeated administration of dapirolizumab pegol in a randomised phase I study is well tolerated and accompanied by improvements in several composite measures of systemic lupus erythematosus disease activity and changes in whole blood transcriptomic profiles","volume":"76","author":"Chamberlain","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.molmed.2019.05.009_bb0225","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.bbrc.2018.03.099","article-title":"RD-05, a novel anti-CD154 antibody, efficiently inhibits generation of anti-drug antibody without the risk of thrombus formation in non-human primates","volume":"498","author":"Lee","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.molmed.2019.05.009_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23051153","article-title":"Design, Synthesis, and Evaluation of Novel Immunomodulatory Small Molecules Targeting the CD40(-)CD154 Costimulatory Protein-Protein Interaction","volume":"23","author":"Bojadzic","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.molmed.2019.05.009_bb0235","doi-asserted-by":"crossref","first-page":"8906","DOI":"10.1021\/acs.jmedchem.7b01154","article-title":"Small-Molecule Inhibitors of the CD40-CD40L Costimulatory Protein-Protein Interaction","volume":"60","author":"Chen","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.molmed.2019.05.009_bb0240","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00109-008-0416-1","article-title":"Inhibition of CD40-CD154 costimulatory pathway by a cyclic peptide targeting CD154","volume":"87","author":"Deambrosis","year":"2009","journal-title":"J.\u00a0Mol. Med. (Berl)"},{"key":"10.1016\/j.molmed.2019.05.009_bb0245","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1172\/JCI116575","article-title":"Attenuation of colitis in the cotton-top tamarin by anti-alpha 4 integrin monoclonal antibody","volume":"92","author":"Podolsky","year":"1993","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.molmed.2019.05.009_bb0250","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1053\/gast.1996.v111.pm8898653","article-title":"Rapid resolution of chronic colitis in the cotton-top tamarin with an antibody to a gut-homing integrin alpha 4 beta 7","volume":"111","author":"Hesterberg","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.molmed.2019.05.009_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2011.06.008","article-title":"Targeting chemokine receptors in chronic inflammatory diseases: an extensive review","volume":"133","author":"Koelink","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.molmed.2019.05.009_bb0260","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/icb.2010.158","article-title":"CXCR3 ligands: redundant, collaborative and antagonistic functions","volume":"89","author":"Groom","year":"2011","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.molmed.2019.05.009_bb0265","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.dld.2016.03.024","article-title":"Innate and adaptive immunity in self-reported nonceliac gluten sensitivity versus celiac disease","volume":"48","author":"Di Sabatino","year":"2016","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.molmed.2019.05.009_bb0270","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1136\/gut.37.6.766","article-title":"Gluten specific, HLA-DQ restricted T\u00a0cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon gamma","volume":"37","author":"Nilsen","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.molmed.2019.05.009_bb0275","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/73200","article-title":"In\u00a0vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope","volume":"6","author":"Anderson","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2019.05.009_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089068","article-title":"Role of CXCR3\/CXCL10 axis in immune cell recruitment into the small intestine in celiac disease","volume":"9","author":"Bondar","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.molmed.2019.05.009_bb0285","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cytogfr.2014.01.006","article-title":"CXCR3, CXCL10 and type 1 diabetes","volume":"25","author":"Antonelli","year":"2014","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.molmed.2019.05.009_bb0290","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/NEN.0b013e318197eca7","article-title":"Expression of chemokines and their receptors by human brain endothelium: implications for multiple sclerosis","volume":"68","author":"Subileau","year":"2009","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.molmed.2019.05.009_bb0295","doi-asserted-by":"crossref","first-page":"6873","DOI":"10.1073\/pnas.96.12.6873","article-title":"CCR5(+) and CXCR3(+) T\u00a0cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions","volume":"96","author":"Balashov","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2019.05.009_bb0300","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1172\/JCI1422","article-title":"The chemokine receptors CXCR3 and CCR5 mark subsets of T\u00a0cells associated with certain inflammatory reactions","volume":"101","author":"Qin","year":"1998","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.molmed.2019.05.009_bb0305","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1172\/JCI77837","article-title":"CXCR3(+)CCR5(+) T\u00a0cells and autoimmune diseases: guilty as charged?","volume":"124","author":"Mackay","year":"2014","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.molmed.2019.05.009_bb0310","doi-asserted-by":"crossref","first-page":"6012715","DOI":"10.1155\/2016\/6012715","article-title":"Chemokines and Chemokine Receptors in the Development of Lupus Nephritis","volume":"2016","author":"Liao","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.molmed.2019.05.009_bb0315","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1136\/annrheumdis-2018-213257","article-title":"Association of circulating CXCL10 and CXCL11 with systemic sclerosis","volume":"77","author":"Crescioli","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.molmed.2019.05.009_bb0320","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/labinvest.3780242","article-title":"Potential role of the chemokine receptors CXCR3, CCR4, and the integrin alphaEbeta7 in the pathogenesis of psoriasis vulgaris","volume":"81","author":"Rottman","year":"2001","journal-title":"Lab. Investig."},{"key":"10.1016\/j.molmed.2019.05.009_bb0325","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/1096-9896(200108)194:4<397::AID-PATH899>3.0.CO;2-S","article-title":"Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation","volume":"194","author":"Flier","year":"2001","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.molmed.2019.05.009_bb0330","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.3389\/fimmu.2018.01090","article-title":"The CXC Chemokine Receptor 3 Inhibits Autoimmune Cholangitis via CD8(+) T Cells but Promotes Colitis via CD4(+) T\u00a0Cells","volume":"9","author":"Liu","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molmed.2019.05.009_bb0335","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2337\/db16-0547","article-title":"Islet-Expressed CXCL10 Promotes Autoimmune Destruction of Islet Isografts in Mice With Type 1 Diabetes","volume":"66","author":"Bender","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.molmed.2019.05.009_bb0340","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.3389\/fimmu.2017.01432","article-title":"Development of Novel Promiscuous Anti-Chemokine Peptibodies for Treating Autoimmunity and Inflammation","volume":"8","author":"Abraham","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molmed.2019.05.009_bb0345","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1002\/art.34330","article-title":"A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis","volume":"64","author":"Yellin","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.molmed.2019.05.009_bb0350","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/17460441.2017.1268597","article-title":"Designing small molecule CXCR3 antagonists","volume":"12","author":"Pease","year":"2017","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.molmed.2019.05.009_bb0355","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJMoa0802905","article-title":"Long-term control of HIV by CCR5 Delta32\/Delta32 stem-cell transplantation","volume":"360","author":"Hutter","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.molmed.2019.05.009_bb0360","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.molmed.2015.11.004","article-title":"HIV-1 Eradication: Early Trials (and Tribulations)","volume":"22","author":"Spivak","year":"2016","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.molmed.2019.05.009_bb0365","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrrheum.2015.157","article-title":"Successes and failures of chemokine-pathway targeting in rheumatoid arthritis","volume":"12","author":"Szekanecz","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.molmed.2019.05.009_bb0370","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pharmthera.2017.11.001","article-title":"The sphingosine 1-phosphate receptor modulator fingolimod as a therapeutic agent: Recent findings and new perspectives","volume":"185","author":"Huwiler","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.molmed.2019.05.009_bb0375","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1177\/1756285616628766","article-title":"Fingolimod in the treatment of relapsing-remitting multiple sclerosis: long-term experience and an update on the clinical evidence","volume":"9","author":"Khatri","year":"2016","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.molmed.2019.05.009_bb0380","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1084\/jem.192.5.761","article-title":"Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: Epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity","volume":"192","author":"Kunkel","year":"2000","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.molmed.2019.05.009_bb0385","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0092-8674(93)90305-A","article-title":"Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1","volume":"74","author":"Berlin","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2019.05.009_bb0390","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0092-8674(95)90491-3","article-title":"alpha 4 integrins mediate lymphocyte attachment and rolling under physiologic flow","volume":"80","author":"Berlin","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2019.05.009_bb0395","first-page":"97","article-title":"Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue","volume":"151","author":"Briskin","year":"1997","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.molmed.2019.05.009_bb0400","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/2050640614540154","article-title":"Tetramer-visualized gluten-specific CD4+ T\u00a0cells in blood as a potential diagnostic marker for coeliac disease without oral gluten challenge","volume":"2","author":"Christophersen","year":"2014","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.molmed.2019.05.009_bb0405","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1172\/JCI98819","article-title":"Disease-driving CD4+ T\u00a0cell clonotypes persist for decades in celiac disease","volume":"128","author":"Risnes","year":"2018","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.molmed.2019.05.009_bb0410","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1182\/blood-2005-07-2860","article-title":"Gut-associated lymphoid tissue-primed CD4+ T\u00a0cells display CCR9-dependent and -independent homing to the small intestine","volume":"107","author":"Stenstad","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2019.05.009_bb0415","doi-asserted-by":"crossref","first-page":"10122","DOI":"10.1073\/pnas.0700269104","article-title":"Differential homing mechanisms regulate regionalized effector CD8alphabeta+ T\u00a0cell accumulation within the small intestine","volume":"104","author":"Stenstad","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2019.05.009_bb0420","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/ajg.2011.24","article-title":"CD62L(neg)CD38(+) expression on circulating CD4(+) T\u00a0cells identifies mucosally differentiated cells in protein fed mice and in human celiac disease patients and controls","volume":"106","author":"du Pre","year":"2011","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.molmed.2019.05.009_bb0425","first-page":"119","article-title":"CCR9 antagonism: potential in the treatment of Inflammatory Bowel Disease","volume":"8","author":"Wendt","year":"2015","journal-title":"Clin. Exp. Gastroenterol."},{"key":"10.1016\/j.molmed.2019.05.009_bb0430","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1053\/j.gastro.2006.08.031","article-title":"Antibody blockade of CCL25\/CCR9 ameliorates early but not late chronic murine ileitis","volume":"131","author":"Rivera-Nieves","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.molmed.2019.05.009_bb0435","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/MPG.0b013e31821a23d0","article-title":"European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease","volume":"54","author":"Husby","year":"2012","journal-title":"J.\u00a0Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.molmed.2019.05.009_bb0440","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1136\/gutjnl-2013-306578","article-title":"Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology","volume":"63","author":"Ludvigsson","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.molmed.2019.05.009_bb0445","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijfoodmicro.2016.06.014","article-title":"Nutritional therapy - Facing the gap between coeliac disease and gluten-free food","volume":"239","author":"Foschia","year":"2016","journal-title":"Int. J. Food Microbiol."},{"key":"10.1016\/j.molmed.2019.05.009_bb0450","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/ng.3822","article-title":"Immunosequencing identifies signatures of cytomegalovirus exposure history and HLA-mediated effects on the T\u00a0cell repertoire","volume":"49","author":"Emerson","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2019.05.009_bb0455","doi-asserted-by":"crossref","first-page":"886 e6","DOI":"10.1053\/j.gastro.2017.11.006","article-title":"HLA-DQ-Gluten Tetramer Blood Test Accurately Identifies Patients With and\u00a0Without Celiac Disease in Absence of Gluten\u00a0Consumption","volume":"154","author":"Sarna","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.molmed.2019.05.009_bb0460","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1136\/gutjnl-2017-314461","article-title":"HLA-DQ:gluten tetramer test in blood gives better detection of coeliac patients than biopsy after 14-day gluten challenge","volume":"67","author":"Sarna","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.molmed.2019.05.009_bb0465","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaw7756","article-title":"Cytokine release and gastrointestinal symptoms after gluten challenge in celiac disease","author":"Goel","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.molmed.2019.05.009_bb0470","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1365-2249.2012.04597.x","article-title":"Short wheat challenge is a reproducible in-vivo assay to detect immune response to gluten","volume":"169","author":"Camarca","year":"2012","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.molmed.2019.05.009_bb0475","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/cei.12232","volume":"175","author":"Ontiveros","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.molmed.2019.05.009_bb0480","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1111\/j.1572-0241.2007.01360.x","article-title":"Fate of five celiac disease-associated antibodies during normal diet in genetically at-risk children observed from birth in a natural history study","volume":"102","author":"Simell","year":"2007","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.molmed.2019.05.009_bb0485","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1056\/NEJMoa1313977","article-title":"Risk of pediatric celiac disease according to HLA haplotype and country","volume":"371","author":"Liu","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.molmed.2019.05.009_bb0490","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1056\/NEJMoa1404172","article-title":"Randomized feeding intervention in infants at high risk for celiac disease","volume":"371","author":"Vriezinga","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.molmed.2019.05.009_bb0495","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1056\/NEJMoa1400697","article-title":"Introduction of gluten, HLA status, and the risk of celiac disease in children","volume":"371","author":"Lionetti","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.molmed.2019.05.009_bb0500","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.4049\/jimmunol.1601693","article-title":"T Cells in Celiac Disease","volume":"198","author":"Jabri","year":"2017","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.molmed.2019.05.009_bb0505","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.bpg.2015.04.001","article-title":"T-cell and B-cell immunity in celiac disease","volume":"29","author":"du Pre","year":"2015","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.molmed.2019.05.009_bb0510","doi-asserted-by":"crossref","first-page":"41ra51","DOI":"10.1126\/scitranslmed.3001012","article-title":"Comprehensive, quantitative mapping of T\u00a0cell epitopes in gluten in celiac disease","volume":"2","author":"Tye-Din","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.molmed.2019.05.009_bb0515","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/MPG.0b013e3181668635","article-title":"Oats do not induce systemic or mucosal autoantibody response in children with coeliac disease","volume":"48","author":"Koskinen","year":"2009","journal-title":"J.\u00a0Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.molmed.2019.05.009_bb0520","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jaut.2014.10.003","article-title":"Ingestion of oats and barley in patients with celiac disease mobilizes cross-reactive T\u00a0cells activated by avenin peptides and immuno-dominant hordein peptides","volume":"56","author":"Hardy","year":"2015","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.molmed.2019.05.009_bb0525","doi-asserted-by":"crossref","first-page":"787-798 e4","DOI":"10.1053\/j.gastro.2017.05.016","article-title":"Similar Responses of Intestinal T Cells From Untreated Children and Adults With Celiac Disease to Deamidated Gluten Epitopes","volume":"153","author":"Raki","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.molmed.2019.05.009_bb0530","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1084\/jem.178.1.187","article-title":"Gliadin-specific, HLA-DQ(\u03b11*0501,\u03b21*0201) restricted T\u00a0cells isolated from the small intestinal mucosa of\u00a0celiac\u00a0disease patients","volume":"178","author":"Lundin","year":"1993","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.molmed.2019.05.009_bb0535","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nm.3868","article-title":"Metabolic control of type 1 regulatory T\u00a0cell differentiation by AHR and HIF1-alpha","volume":"21","author":"Mascanfroni","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2019.05.009_bb0540","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1016\/j.celrep.2017.08.078","article-title":"Human Tissue-Resident Memory T Cells Are Defined by Core Transcriptional and Functional Signatures in Lymphoid and Mucosal Sites","volume":"20","author":"Kumar","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2019.05.009_bb0545","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/eji.200636435","article-title":"Transient expression of FOXP3 in human activated nonregulatory CD4+ T\u00a0cells","volume":"37","author":"Wang","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.molmed.2019.05.009_bb0550","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nm.3179","article-title":"Coexpression of CD49b and LAG-3 identifies human and mouse\u00a0T regulatory type 1 cells","volume":"19","author":"Gagliani","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2019.05.009_bb0555","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nri3405","article-title":"Molecular mechanisms of T\u00a0cell co-stimulation and co-inhibition","volume":"13","author":"Chen","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molmed.2019.05.009_bb0560","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/COC.0000000000000239","article-title":"CTLA-4 and PD-1 Pathways: Similarities, Differences, and Implications of Their Inhibition","volume":"39","author":"Buchbinder","year":"2016","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.molmed.2019.05.009_bb0565","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cei.12997","article-title":"Immune deficiency and autoimmunity in patients with CTLA-4 (CD152) mutations","volume":"190","author":"Verma","year":"2017","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.molmed.2019.05.009_bb0570","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1084\/jem.20022125","article-title":"The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice","volume":"198","author":"Ansari","year":"2003","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.molmed.2019.05.009_bb0575","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cellimm.2014.05.006","article-title":"The PD-1\/PD-Ls pathway and\u00a0autoimmune diseases","volume":"290","author":"Dai","year":"2014","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.molmed.2019.05.009_bb0580","doi-asserted-by":"crossref","first-page":"76","DOI":"10.14694\/EdBook_AM.2015.35.76","article-title":"Managing immune checkpoint-blocking antibody side effects","author":"Postow","year":"2015","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491419301261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491419301261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T07:18:30Z","timestamp":1761463110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491419301261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":116,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S1471491419301261"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2019.05.009","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic and Diagnostic Implications of T Cell Scarring in Celiac Disease and Beyond","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2019.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}